Ciloa at the Obesity & Weight Loss Drug Development Summit Europe
Robert Mamoun, Co-founder & CEO of Ciloa, will take part in the 2nd Obesity & Weight Loss Drug Development Summit Europe on 28–29 October 2026 in Munich. He will join the Industry Leaders' Fireside Chat and present "A Biomimetic Adiponectin–Extracellular Vesicle (APN-EV) Combined with GLP-1: Efficacy in Preclinic." The talk…
